Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa

Clinical trial NCT00014729 · COMPLETED

Trial details

NCT number: NCT00014729
Sponsor: University of North Carolina
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Epidermolysis Bullosa

Start date: 2000-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.